Announcement on Obtaining Notice of Approval for Clinical Trial
Filed with SSE · · 2 pages · Chinese
Joincare Pharmaceutical Group Industry Co., Ltd. on 6ix
Earlier from Joincare Pharmaceutical Group Industry
- Announcement on Resolutions of the 2024 Annual General Meeting
- Announcement on Progress in Providing Guarantee
- Announcement on Obtaining Production License by Subsidiary in the Netherlands
- Indicative Announcement on Convening the 2024 Annual General Meeting
- Announcement on Holding Subsidiary Livzon Group Planning to Acquire Equity of Vietnam IMP Company
Later from Joincare Pharmaceutical Group Industry
- Announcement on Progress in Providing Entrusted Loans to Holding Subsidiary Jiaozuo Jianfeng
- Announcement on Implementation of Dividend Distribution for 2024
- Indicative Announcement on the Phase Ⅲ Clinical Trial of Recombinant Anti-Human IL-17A/F Humanized Monoclonal Antibody Injection Reaching the Primary Study Endpoint
- Announcement on Resolutions of the 11th Meeting of the 9th Board of Directors
- Indicative Announcement on Acceptance of Applications for Drug Registration and Market Authorization
Follow Joincare Pharmaceutical Group Industry into a list and get an email when it puts out news.
Follow Joincare Pharmaceutical Group Industry